What's New

February 22, 2025: In-Person Meet & Greet in Sparks, Nev.

AFTD Ambassador Scott Oxarart invites anyone impacted by FTD to join others on the FTD journey for a two-mile walk beginning at Nevada Veterans Memorial Plaza in Sparks (300 Howard…

Read More about February 22, 2025: In-Person Meet & Greet in Sparks, Nev.

February 9, 2025: Seattle, Wash. Virtual Meet & Greet

Join and learn from others who understand the FTD journey at this virtual AFTD Meet & Greet event for people in Seattle, Wash., and its surrounding communities on Sunday, February…

Read More about February 9, 2025: Seattle, Wash. Virtual Meet & Greet

Making a Difference: AFTD Introduces First-Ever Advocacy Agenda

AFTD has unveiled a robust and ambitious advocacy agenda for 2025, emphasizing the urgent need to better support families facing FTD while pushing for deeper public investments into FTD research…

Read More about Making a Difference: AFTD Introduces First-Ever Advocacy Agenda

In TEDx Talk, Neuroscientist Shares Her Father’s FTD Story and Her Hope for Dementia Research Breakthroughs

Leila Allen, PhD, of Florida International University (FIU), discussed the groundbreaking dementia research that she and her colleagues are performing with pig models and artificial intelligence during a recently published…

Read More about In TEDx Talk, Neuroscientist Shares Her Father’s FTD Story and Her Hope for Dementia Research Breakthroughs

Extracellular Vesicles in Plasma Could be FTD-ALS Diagnostic Biomarker, Study Finds

A study published in Nature Medicine finds that a type of particle associated with specific cell subtypes could potentially be utilized as a biomarker for FTD and ALS disorders. The…

Read More about Extracellular Vesicles in Plasma Could be FTD-ALS Diagnostic Biomarker, Study Finds

Denali and Takeda Open FTD-GRN Clinical Trial Site at UPenn

Denali Therapeutics and Takeda Pharmaceutical Company’s phase 1/2 clinical trial for FTD caused by GRN mutations is opening its first U.S.-based trial site at the University of Pennsylvania (UPenn). The…

Read More about Denali and Takeda Open FTD-GRN Clinical Trial Site at UPenn

Tips & Advice: Incontinence – A Troubling Symptom

Incontinence is a common symptom of FTD and other dementias. But for both care partners and persons diagnosed, incontinence can be one of the more difficult symptoms to manage or even…

Read More about Tips & Advice: Incontinence – A Troubling Symptom

Ohio Care Partner Shares Story to Help Others on the FTD Journey

Mary Kay Verhoff, a former FTD care partner from Ohio, recently published a book that tells the story of coming to terms with and navigating her husband’s decline from FTD.…

Read More about Ohio Care Partner Shares Story to Help Others on the FTD Journey

January 25, 2025: Virtual Meet & Greet for MT, WY, ND, and SD

Join and learn from others who understand the FTD journey at this virtual AFTD Meet & Greet event for people in Montana, Wyoming, North Dakota, and South Dakota. The event…

Read More about January 25, 2025: Virtual Meet & Greet for MT, WY, ND, and SD

Can a Tau PET Tracer Aid FTD Diagnosis? Study Explores How Tracer Performs in Other Tauopathies

A study published in Science Translational Medicine explores how well the brain imaging tau PET tracer F-MK-6240 (flortaucipir) captures the presence of underlying protein clumps seen in post-mortem Alzheimer’s tissue.…

Read More about Can a Tau PET Tracer Aid FTD Diagnosis? Study Explores How Tracer Performs in Other Tauopathies